Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Lumiracoxib
Also marketed in the EU under the name(s): Exforge, Frexocel, Lumiracoxib, Prexige, Stellige
Active substance: Lumiracoxib
Indication: Not available
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/11/2005 Referral EMEA/H/A-31/632 (2005)4721 of 28/11/2005
10/01/2006 Corrigendum (2005)4721 of 28/11/2005
29/01/2008 Referral EMEA/H/A-107/945 (2008)396 of 25/01/2008
07/03/2008 Referral EMEA/H/A-107/945 (2008)973 of 06/03/2008